BlackBerry’s interim CEO may believe that the company’s future is bright, but unfortunately the market thinks a bit different, and more and more of its clients are switching to iPhone or Android. The most recent in line is another US-based client, the world’s biggest drug maker, Pfizer Inc.
While some of BlackBerry’s biggest clients – such as the US Defense Department – are sticking with the struggling Canadian smartphone manufacturer, Pfizer believes the company is in a volatile state, and in a memo sent to employees, the company cited concerns that the Canadian company may not be around in the future, or may have interrupted service.
“In response to declining sales, the company is in a volatile state,” New York-based Pfizer told employees in a memo obtained by Bloomberg News. “We recommend that BlackBerry clients use their BlackBerry devices and plan to migrate to a new device at normal contract expiration.”
Sources speaking with AllThingsD say that Pfizer has 90,000 employees, with a “huge” portion of those currently using BlackBerries.
The Canadian smartphone manufacturer has been facing a tough year. After the BlackBerry 10 OS and the newly introduced devices failed to charm the market, the company attempted a sale. FairFax placed a $4.7 bid for the struggling company, but sales plans were ultimately dropped, and BlackBerry received a $1 billion capital injection and a new, interim CEO, John Chen.